SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
ISIN CA89620X5064
USD
  • Trillium Therapeutics Inc
    Börse Börse Frankfurt
    EUR
  • Trillium Therapeutics Inc
    Börse Nasdaq
    ISIN CA89620X5064 WKN: A12FG3
    Symbol TRIL
    USD
  • ISIN CA89620X5064 WKN: A12FG3
    Symbol TRIL
    USD
  • ISIN CA89620X5064
    CAD
ISIN CA89620X5064
WKN A12FG3
Symbol TRIL
Währung USD
Marktkapitalisierung 691.000.000
Mitarbeiter 33

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 6,69 EUR -1,53% 

69 News & Informationen zur Trillium Therapeutics Inc Aktie

  • SHAREHOLDER ALERT: WeissLaw LLP Reminds TRIL, SIC, SAFM, and GRA Shareholders About Its Ongoing Investigations
    marketscreener.com

    SHAREHOLDER ALERT: WeissLaw LLP Reminds TRIL, SIC, SAFM, and GRA Shareholders About Its Ongoing Investigations

    NEW YORK, Aug. 30, 2021 /PRNewswire/ — If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your… | August 30, 2021

  • SHAREHOLDER ALERT: WeissLaw LLP Reminds TRIL, SIC, SAFM, and GRA Shareholders About Its Ongoing Investigations
    prnewswire.com

    SHAREHOLDER ALERT: WeissLaw LLP Reminds TRIL, SIC, SAFM, and GRA Shareholders About Its Ongoing Investigations

    /PRNewswire/ — If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this…

  • INVESTIGATION: Halper Sadeh LLP Investigates LMRK, HFC, NLOK, TRIL, LDL; Shareholders are Encouraged to Contact the Firm
    prnewswire.com

    INVESTIGATION: Halper Sadeh LLP Investigates LMRK, HFC, NLOK, TRIL, LDL; Shareholders are Encouraged to Contact the Firm

    /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Landmark Infrastructure Partners LP…

  • Pfizer's Covid Technology May Have Cancer Applications
    gurufocus.com

    Pfizer's Covid Technology May Have Cancer Applications

    GuruFocus Article or News written by Barry Cohen and the topic is about: The mRNA-produced vaccines are now being tested in lung and breast cancers

  • TSX futures fall as gold slips
    marketscreener.com

    TSX futures fall as gold slips

    Futures for Canada's main stock index inched lower on Tuesday on weakness in bullion, while solid earnings from Canadian banks and higher crude prices limited the losses. … | August 24, 2021

  • Morning Update: Catholic Church charity set up to pay survivors of residential schools spent $6.46-million on expenses, records show
    theglobeandmail.com

    Morning Update: Catholic Church charity set up to pay survivors of residential schools spent $6.46-million on expenses, records show

    Plus, new dangers await Afghan evacuees making their way on foot to Turkey, while those hoping to get on Canadian flights say they aren’t getting sufficient information from officials

  • 60 Biggest Movers From Yesterday
    markets.businessinsider.com

    60 Biggest Movers From Yesterday

    Gainers Trillium Therapeutics Inc. (NASDAQ:TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pf…

  • Trillium Therapeutics Aktie – Starkes Kursplus dank Pfizer-Übernahme
    etf-nachrichten.de

    Trillium Therapeutics Aktie – Starkes Kursplus dank Pfizer-Übernahme

    Trillium Therapeutics Aktie steigt um 184,51 %, nachdem bekannt wurde, dass Pfizer das Unternehmen kauft. Lohnt sich noch ein Einstieg?

  • Pfizer to acquire cancer drugmaker Trillium for $2.3 billion
    thehindubusinessline.com

    Pfizer to acquire cancer drugmaker Trillium for $2.3 billion

    It invested $25 million in Trillium in September as part of its ‘Breakthrough Growth Initiative’

  • Commodore Capital Lp Buys Celcuity Inc, C4 Therapeutics Inc, Cytokinetics Inc, Sells , Trillium Therapeutics Inc, Relmada Therapeutics Inc
    gurufocus.com

    Commodore Capital Lp Buys Celcuity Inc, C4 Therapeutics Inc, Cytokinetics Inc, Sells , Trillium Therapeutics Inc, Relmada Therapeutics Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Wall St gains, Nasdaq notches record closing high on full vaccine approval
    theedgemarkets.com

    Wall St gains, Nasdaq notches record closing high on full vaccine approval

    Wall Street rallied on Monday, and the Nasdaq reached an all-time closing high as sentiment was boosted by full FDA approval of a COVID-19 vaccine and market participants looked ahead to the Jackson Hole Symposium expected to convene later this week. All three major U.S. stock indexes ended the session sharply higher, with the S&P 500 in the session's final minutes just failing to hold what would have been a record-high close.

  • TSX Ends On Strong Note As Energy, Materials Shares Rally
    markets.businessinsider.com

    TSX Ends On Strong Note As Energy, Materials Shares Rally

    (RTTNews) – The Canadian stock market closed notably higher on Monday, lifted by strong gains in energy, materials and healthcare shares. Firm co…

  • TSX rises 0.68% to 20,477.26
    marketscreener.com

    TSX rises 0.68% to 20,477.26

    * The Toronto Stock Exchange's TSX rises 0.68 percent to 20,477.26 
    * Leading the index were Trillium Therapeutics Inc , up 184.5%, MAG Silver Corp, up 8.3%, and New Gold… | August 23, 2021

  • Evening Update: Health care debate takes over federal election campaign
    theglobeandmail.com

    Evening Update: Health care debate takes over federal election campaign

    Also: Canada will support G7 sanctions against the Taliban, Trudeau says

  • U.S. Stocks Close On Firm Note
    markets.businessinsider.com

    U.S. Stocks Close On Firm Note

    (RTTNews) – U.S. stocks closed on a strong note on Monday with several counters from across various sectors attracting buyers. Firm commodity pri…

  • U.S. Stocks Close On Firm Note
    rttnews.com

    U.S. Stocks Close On Firm Note

    U.S. stocks closed on a strong note on Monday with several counters from across various sectors attracting buyers..

  • Trillium, Analog Devices rise: General Motors, Lennar fall
    abcnews.go.com

    Trillium, Analog Devices rise: General Motors, Lennar fall

    Stocks that traded heavily or had substantial price changes Monday: Trillium, Analog Devices rise; General Motors, Lennar fall

  • ROUNDUP/Aktien New York Schluss: Erholung verhilft Nasdaq und S&P zu Rekorden
    finanzen.net

    ROUNDUP/Aktien New York Schluss: Erholung verhilft Nasdaq und S&P zu Rekorden

    ROUNDUP/Aktien New York Schluss: Erholung verhilft Nasdaq und S&P zu Rekorden | Nachricht | finanzen.net

  • Aktien New York Schluss: Erholung verhilft Nasdaq und S&P zu Rekorden
    cash.ch

    Aktien New York Schluss: Erholung verhilft Nasdaq und S&P zu Rekorden

    An den US-Börsen ist die am Freitag begonnene Erholung zu Wochenbeginn weiter gegangen. Händlern zufolge greifen die Anleger auf dem ermässigten Kursniveau neuerdings wieder etwas beherzter zu – und die Wahl fiel dabei…

  • U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.61% By Investing.com
    investing.com

    U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.61% By Investing.com

    U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.61%

  • US stocks close at fresh records amid FDA approval of COVID-19 vaccine
    businessinsider.com

    US stocks close at fresh records amid FDA approval of COVID-19 vaccine

    Xinhua/Wang Ying/ Getty Images US stocks closed at record highs on Monday amid the FDA's approval of Pfizer's COVID vaccine.The S&…

  • Moderna : S&P 500, Nasdaq on course for record closing highs on vaccine boost
    marketscreener.com

    Moderna : S&P 500, Nasdaq on course for record closing highs on vaccine boost

    Wall Street rallied on Monday,
    coming off a tumultuous week as investors digested full FDA
    approval of a COVID-19 vaccine and looked ahead to the Jackson
    Hole Symposium expected to convene later this… | August 23, 2021

  • Mid-Afternoon Market Update: Dow Gains 270 Points; Vivos Therapeutics Shares Spike Higher
    markets.businessinsider.com

    Mid-Afternoon Market Update: Dow Gains 270 Points; Vivos Therapeutics Shares Spike Higher

    Toward the end of trading Monday, the Dow traded up 0.77% to 35,392.00 while the NASDAQ rose 1.64% to 14,956.54. The S&P also rose, gaining 1….

  • S&P 500, Nasdaq on course for record closing highs on vaccine boost
    financialpost.com

    S&P 500, Nasdaq on course for record closing highs on vaccine boost

    NEW YORK — Wall Street rallied on Monday, coming off a tumultuous week as investors digested full FDA approval of a COVID-19 vaccine and looked ahead to the…

  • Canadian Market Firmly Up In Positive Territory; Trillium Therapeutics Skyrockets
    markets.businessinsider.com

    Canadian Market Firmly Up In Positive Territory; Trillium Therapeutics Skyrockets

    (RTTNews) – The Canadian stock market is up firmly in positive territory Monday afternoon, riding on strong gains in healthcare, energy and materi…

  • S&P 500, Nasdaq Ride Energy, Tech Rally to Record Highs By Investing.com
    investing.com

    S&P 500, Nasdaq Ride Energy, Tech Rally to Record Highs By Investing.com

    S&P 500, Nasdaq Ride Energy, Tech Rally to Record Highs

  • Pfizer to acquire Canadian cancer drugmaker Trillium for $2.3 billion
    financialpost.com

  • Mid-Day Market Update: Crude Oil Surges 5%; Staffing 360 Solutions Shares Plunge
    benzinga.com

    Mid-Day Market Update: Crude Oil Surges 5%; Staffing 360 Solutions Shares Plunge

    Midway through trading Monday, the Dow traded up 0.77% to 35,391.72 while the NASDAQ rose 1.35% to 14,912.95. The S&P also rose, gaining 0.95% to …

  • Trillium Therapeutics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Trillium Therapeutics Inc. Is...
    marketscreener.com

    Trillium Therapeutics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Trillium Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact th

    Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Trillium Therapeutics Inc. to Pfizer Inc. for $18.50 per share in cash is fair to Trillium… | August 23, 2021

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

ETFs die in Trillium Therapeutics Inc investieren

Dir gefallen die Informationen zu Trillium Therapeutics Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Trillium Therapeutics Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Trillium Therapeutics Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Trillium Therapeutics Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect